Sarah Constantin, Ph.D.

About Sarah Constantin, Ph.D.

Sarah is the founder and CEO of Daphnia Labs, a drug discovery startup using machine learning to screen for aging-modulating drugs in vivo. Previously, she has built machine learning tools for biotech, autonomous vehicles, and cybersecurity. She received her PhD in math from Yale in 2015, focusing on manifold learning with applications to systems biology.

Campaigns Supported

Successful

MitoSENS Mitochondrial Repair Project

Engineering backup copies of mitochondrial genes to place in the nucleus of the cell, aiming to prevent age-related damage and restore lost mitochondrial function.

153% Funded
$46,128 Funded
campaign
complete

Related Organizations

Stay Connected